Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss (Unaudited)

v3.19.3
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
EXPENSES        
Research and development $ 1,824 $ 1,541 $ 7,911 $ 3,787
General and administrative 1,893 1,753 5,408 5,317
Total operating expenses 3,717 3,294 13,319 9,104
OTHER INCOME (EXPENSE)        
Interest income 40 61 143 88
Other expenses 4 (7) (25) (34)
Total other income (expense) 44 54 118 54
Net loss (3,673) (3,240) (13,201) (9,050)
OTHER COMPREHENSIVE LOSS        
Comprehensive loss $ (3,673) $ (3,240) $ (13,201) $ (9,050)
Basic and diluted net loss per common share $ (0.45) $ (0.71) $ (1.80) $ (3.70)
Weighted average shares used in computation of basic and diluted net loss per common share 8,100,249 4,533,943 7,342,087 2,448,962